Literature DB >> 10087499

Combinatorial docking and combinatorial chemistry: design of potent non-peptide thrombin inhibitors.

H J Böhm1, D W Banner, L Weber.   

Abstract

A computational algorithm was used to design automatically novel thrombin inhibitors that are available from a single-step chemical reaction. The compounds do not contain amide bonds, are achiral and have a molecular weight below 400. Of the 10 compounds that were synthesized, five bind to thrombin with a Ki in the nanomolar range. Subsequent X-ray structure determination of the thrombin-inhibitor complex for the best compound (Ki = 95 nM) confirms the predicted binding mode. The novel algorithm is applicable to a broad range of chemical reactions.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10087499     DOI: 10.1023/a:1008040531766

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  14 in total

1.  Molecular Recognition of Proteinminus signLigand Complexes: Applications to Drug Design.

Authors:  Robert E. Babine; Steven L. Bender
Journal:  Chem Rev       Date:  1997-08-05       Impact factor: 60.622

2.  Stable expression and purification of a secreted human recombinant prethrombin-2 and its activation to thrombin.

Authors:  G Russo; A Gast; E J Schlaeger; A Angiolillo; C Pietropaolo
Journal:  Protein Expr Purif       Date:  1997-07       Impact factor: 1.650

3.  The computer program LUDI: a new method for the de novo design of enzyme inhibitors.

Authors:  H J Böhm
Journal:  J Comput Aided Mol Des       Date:  1992-02       Impact factor: 3.686

4.  Crystallographic analysis at 3.0-A resolution of the binding to human thrombin of four active site-directed inhibitors.

Authors:  D W Banner; P Hadváry
Journal:  J Biol Chem       Date:  1991-10-25       Impact factor: 5.157

5.  Towards the automatic design of synthetically accessible protein ligands: peptides, amides and peptidomimetics.

Authors:  H J Böhm
Journal:  J Comput Aided Mol Des       Date:  1996-08       Impact factor: 3.686

Review 6.  Computational tools for structure-based ligand design.

Authors:  H J Böhm
Journal:  Prog Biophys Mol Biol       Date:  1996       Impact factor: 3.667

Review 7.  Current methods for site-directed structure generation.

Authors:  R A Lewis; A R Leach
Journal:  J Comput Aided Mol Des       Date:  1994-08       Impact factor: 3.686

8.  The development of a simple empirical scoring function to estimate the binding constant for a protein-ligand complex of known three-dimensional structure.

Authors:  H J Böhm
Journal:  J Comput Aided Mol Des       Date:  1994-06       Impact factor: 3.686

9.  Viracept (nelfinavir mesylate, AG1343): a potent, orally bioavailable inhibitor of HIV-1 protease.

Authors:  S W Kaldor; V J Kalish; J F Davies; B V Shetty; J E Fritz; K Appelt; J A Burgess; K M Campanale; N Y Chirgadze; D K Clawson; B A Dressman; S D Hatch; D A Khalil; M B Kosa; P P Lubbehusen; M A Muesing; A K Patick; S H Reich; K S Su; J H Tatlock
Journal:  J Med Chem       Date:  1997-11-21       Impact factor: 7.446

10.  Design and synthesis of potent and highly selective thrombin inhibitors.

Authors:  K Hilpert; J Ackermann; D W Banner; A Gast; K Gubernator; P Hadváry; L Labler; K Müller; G Schmid; T B Tschopp
Journal:  J Med Chem       Date:  1994-11-11       Impact factor: 7.446

View more
  8 in total

1.  De novo design of molecular architectures by evolutionary assembly of drug-derived building blocks.

Authors:  G Schneider; M L Lee; M Stahl; P Schneider
Journal:  J Comput Aided Mol Des       Date:  2000-07       Impact factor: 3.686

2.  Combinatorial computational method gives new picomolar ligands for a known enzyme.

Authors:  Bartosz A Grzybowski; Alexey V Ishchenko; Chu-Young Kim; George Topalov; Robert Chapman; David W Christianson; George M Whitesides; Eugene I Shakhnovich
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-29       Impact factor: 11.205

3.  A validation study on the practical use of automated de novo design.

Authors:  Martin Stahl; Nikolay P Todorov; Tim James; Harald Mauser; Hans-Joachim Boehm; Philip M Dean
Journal:  J Comput Aided Mol Des       Date:  2002-07       Impact factor: 3.686

4.  Designing the molecular future.

Authors:  Gisbert Schneider
Journal:  J Comput Aided Mol Des       Date:  2011-11-30       Impact factor: 3.686

5.  Minimal pharmacophoric elements and fragment hopping, an approach directed at molecular diversity and isozyme selectivity. Design of selective neuronal nitric oxide synthase inhibitors.

Authors:  Haitao Ji; Benjamin Z Stanton; Jotaro Igarashi; Huiying Li; Pavel Martásek; Linda J Roman; Thomas L Poulos; Richard B Silverman
Journal:  J Am Chem Soc       Date:  2008-03-06       Impact factor: 15.419

6.  Drug design for ever, from hype to hope.

Authors:  G Seddon; V Lounnas; R McGuire; T van den Bergh; R P Bywater; L Oliveira; G Vriend
Journal:  J Comput Aided Mol Des       Date:  2012-01-18       Impact factor: 3.686

7.  Computational Methods Applied to Rational Drug Design.

Authors:  David Ramírez
Journal:  Open Med Chem J       Date:  2016-04-26

Review 8.  Docking, virtual high throughput screening and in silico fragment-based drug design.

Authors:  Vincent Zoete; Aurélien Grosdidier; Olivier Michielin
Journal:  J Cell Mol Med       Date:  2009-01-21       Impact factor: 5.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.